Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa

Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa

Introduction: The increasing resistance of Pseudomonas aeruginosa against cefepime requires a better understanding of hospital epidemiology in order to retain this drug as a therapeutic option. Aim: The aim of this study was to identify risk factors associated with healthcare associated infections (...

Full description

Bibliographic Details
Main Authors:	Folić Marko M., Đorđević Zorana M., Milovanović Dragan R., Ružić-Zečević Dejana T., Rosić Nikola V., Janković Slobodan M.
Format:	Article
Language:	English
Published:	Srpsko lekarsko drustvo 2020-01-01
Series:	Hospital Pharmacology
Subjects:	pseudomonas aeruginosa cefepime antibiotics resistance
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2020/2334-94922002923F.pdf

Similar Items

Cefepime-Resistant Pseudomonas aeruginosa
by: Ehimare Akhabue, et al.
Published: (2011-06-01)

Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
by: Usman M, et al.
Published: (2023-09-01)

Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
by: Ting-Yi Su, et al.
Published: (2017-07-01)

Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam
by: Andrea M. Hujer, et al.
Published: (2023-12-01)

Antimicrobial Resistance Pattern of Pseudomonas aeruginosa: An 11-Year Experience in a Tertiary Care Hospital in Makkah, Saudi Arabia
by: Momenah AM, et al.
Published: (2023-06-01)

Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of Acinetobacter spp. and Pseudomonas aeruginosa Isolated from Patients with Nosocomial Infections
by: Zorana M. Djordjevic, et al.
Published: (2017-12-01)

In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
by: Po-Yu Liu, et al.
Published: (2022-10-01)

Lessons Learned from Surveillance of Antimicrobial Susceptibilities of Pseudomonas aeruginosa at a Large Academic Medical Center
by: Brett H. Heintz, et al.
Published: (2010-04-01)

Equilibrium in the System of Glauconite – Aqueous Solution of Cefepime Hydrochloride
by: Tatiana A. Krysanova, et al.
Published: (2019-12-01)

Clinical Pharmacology of Cefepime in Infants and Children
by: Gian Maria Pacifici, et al.
Published: (2017-04-01)

Negative myoclonus as a manifestation of cefepime neurotoxicity
by: Daichi Umemoto, et al.
Published: (2024-01-01)

Evaluation of cefepime kinetic variables and milk production volume in goats Avaliação das variáveis cinéticas de cefepime e da produção de leite em cabras
by: R. Rule, et al.
Published: (2004-02-01)

Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against <i>Pseudomonas aeruginosa</i>
by: Rayhane Ben-Khalifa, et al.
Published: (2021-10-01)

The clinical characteristics of adult bacterial meningitis caused by non-Pseudomonas (Ps.) aeruginosa Pseudomonas species: A clinical comparison with Ps. aeruginosa meningitis
by: Chi-Ren Huang, et al.
Published: (2018-01-01)

Efficacy and Safety of Cystatin C-Guided Renal Dose Adjustment of Cefepime Treatment in Hospitalized Patients with Pneumonia
by: Min-Chul Kim, et al.
Published: (2020-08-01)

Eosinophilic pneumonia caused by cefepime: A case report and review
by: Bruce M. Jones, et al.
Published: (2021-01-01)

Molecular Characterization of WCK 5222 (Cefepime/Zidebactam)-Resistant Mutants Developed from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate
by: Xiaolei Pan, et al.
Published: (2022-02-01)

Biosurfactant Production by Pseudomonas Aeruginosa 181
by: Yassin Al-Araji, Laith Issa
Published: (2004)

Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
by: Yang Zhao, et al.
Published: (2020-02-01)

Optimisation of the Procedure of Cefepime Extraction from Biological Material
by: A. A. Bezyazychnaya, et al.
Published: (2019-09-01)

MULTIPLE ANTIBIOTIC RESISTANCE OF PSEUDOMONAS AERUGINOSA ISOLATED FROMAL-RAMADI CITY.
by: Salah S.Z Al-Jarrah
Published: (2012-06-01)

Antimicrobial resistance patterns of pseudomonas aeruginosa in a tertiary care hospital
by: Ruby Chattopadhyay, et al.
Published: (2014-01-01)

Determination of four residual solvents in cefepime by headspace gas chromatography
by: Le Wang
Published: (2024-01-01)

A rare case of cefepime-induced cholestatic liver injury
by: Pei-Fei Liao, et al.
Published: (2019-01-01)

Cefepime-Induced Neutropenia: A Case Report and Literature Review
by: Koraysh S, et al.
Published: (2023-04-01)

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
by: Sean N. Avedissian, et al.
Published: (2019-02-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Curus Azimi, et al.
Published: (2012-10-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Hossein Dargahi, et al.
Published: (2012-07-01)

STUDY OF OPTIMUM CONDITIONS FOR PROTEASE ENZYME PRODUCTION BY PSEUDOMONAS AERUGINOSA ISOLATED FROM DIFFERENT CLINICAL SOURCES.
by: MOHAMMED KH. MAHMUOD, et al.
Published: (2014-08-01)

Interaction between hyaluronate and the cell surface of 'Pseudomonas aeruginosa' /
by: 274629 Jager, Karl-Erich, et al.

Infección invasiva por Pseudomonas aeruginosa en Galicia
by: María Teresa Pérez Rodríguez, et al.
Published: (2018-12-01)

Pharmacokinetics of vancomycin in patients with different renal function levels
by: Zaric Radica Zivkovic, et al.
Published: (2018-10-01)

Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and metaanalysis
by: Hamid Vaez, et al.
Published: (2018-01-01)

Synthesis and Physicochemical Properties of Cefepime Derivatives Suitable for Labeling with Gallium-68
by: Przemysław Koźmiński, et al.
Published: (2023-04-01)

Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis
by: Saber Jan, et al.
Published: (2018-03-01)

Chronic Pseudomonas aeruginosa cervical osteomyelitis
by: Sujeet Kumar Meher, et al.
Published: (2016-01-01)

Acute Generalized Exanthematous Pustulosis Induced by Cefepime: A Case Report
by: L.F.F. Botelho, et al.
Published: (2010-06-01)

In vitro study of effects of antibiotics on Pseudomonas aeruginosa biofilm formation
by: Jeevajothi Nathan, Priadarssini
Published: (2017)

Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report
by: Dilip Dubey, et al.
Published: (2023-07-01)

BIOTECHNOLOGY STUDY TO REMOVE NITRATE AND NATRATE BY USING PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM WEST WATER IN BAGHDAD CITY
by: ALI. H HAMMADI, et al.
Published: (2014-08-01)